|
Volumn 353, Issue 9170, 1999, Pages 2132-
|
54-week results on infliximab attract attention at EULAR. European League against Rheumatism.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
INFLIXIMAB;
MONOCLONAL ANTIBODY;
ARTICLE;
ECONOMICS;
HUMAN;
RHEUMATOID ARTHRITIS;
ANTIBODIES, MONOCLONAL;
ARTHRITIS, RHEUMATOID;
HUMANS;
|
EID: 0033583848
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(05)75570-7 Document Type: Article |
Times cited : (6)
|
References (0)
|